|
|
|
Biotechnology for the Non-Biotechnologist |
 |
|
23-25 September 2009
Basel, Switzerland
The purpose of this training course is to provide non-biotechnologists with the basic theory to understand principles, techniques and the potentials of biotechnology.
Biotechnology combines disciplines such as molecular biology, biochemistry, chemistry, microbiology, chemical engineering and computing. This rapidly advancing science offers new and exciting opportunities to mankind, especially in the fight against disease.
Topics to be covered at this meeting:
Day One
- Introduction to Biotechnology
- Introduction to Molecular Biology
- Re-Expression of Proteins
- Development of Production Organisms
- Fermentation Technology and Large Scale Production
Day Two
- Process Optimisation and Scale-Up
- Analysis of Biopharmaceuticals
- Product Recovery and Purification
- Formulation Design of Biopharmaceuticals
- Process Economics
Day Three
- Patenting of Biotech Inventions
- Patent Workshop
- Regulatory Considerations
- Regulatory Applications and Consequences, Comparability and Equivalence
- Advances in Regulation: Biosimilars
- Current and Future Developments
Chairman - Dr Adekunle Onadipe - Associate Research Fellow, Bioprocess R&D Cell Line Development, Pfizer Inc.,USA |
|
|
|
|
|
 |
|
|
 |
Industry Events |
 |
BioPartnering North America™
26-28 February 2012, Vancouver Convention Centre, Vancouver, BC, Canada
BioPartnering North America 2012 (BPN) in Vancouver, Canada brings together senior executives from venture capital firms, major pharmaceutical companies, academic institutions and biotechnology companies of every size from mature to start-up.
More info >> |
|
 |
News and Press Releases |
 |
Record sales of new de-blistering and leak testing equipment at packaging machinery manufacturer, Sepha Ltd
The packaging machinery manufacturer, Sepha Ltd, has reported record sales of its recently extended range of non-destructive leak testing equipment for the world's pharmaceutical packaging industry. With demand up across all major markets, the company says the increase will fund future R&D and enable it to bring forward future innovations aimed at reducing costs and driving quality for pharmaceutical manufacturers and contract packers.
More info >> |
|
|
